Thomas Kohl (physician)

from Wikipedia, the free encyclopedia
Thomas Kohl

Thomas Kohl (born July 28, 1962 in Siegen ) is a German fetal surgeon and university professor.

Life

Kohl studied human medicine at the University of Essen from 1983 to 1990 and obtained his doctorate in 1993 at the Essen University Children's Hospital on "The aerobic-anaerobic threshold for spiroergometric stress in children, adolescents and young adults with chronic kidney failure ".

After his license to practice medicine in 1992, he initially worked as an assistant doctor and research assistant in the children's clinic at the Westphalian Wilhelms University in Münster . There he dealt primarily with the sub-area of pediatric cardiology .

As part of a three-year research stay at the University of California , San Francisco (USA ) funded by the German Research Foundation (DFG) , he began in 1993 and 1996 to develop minimally invasive surgical techniques for treating heart defects in fetuses in the womb.

After his return to Münster, he founded a working group to develop experimental and clinical fetal-cardiac intervention techniques. In addition to his scientific work, he completed specialist training in paediatrics and passed the specialist examination in 2001.

In the same year he completed his habilitation with the topic "Development of minimally invasive fetoscopic techniques for fetal cardiac intervention" and received the Venia Legendi for pediatrics - pediatric cardiology from the medical faculty of the Westphalian Wilhelms University in Münster.

From 2001 to 2002 he worked as a research assistant in the prenatal medicine department at the University Women 's Clinic in Lübeck. In 2002 he moved to the University Women's Clinic in Bonn, where he was appointed Senior Physician for Clinical and Experimental Fetal Cardiology and Fetal Surgery . In 2004 he became senior physician at the German Center for Fetal Surgery & Minimally Invasive Therapy (DZFT), which he founded.

In 2010 he moved to the Gießen and Marburg University Hospital as chief physician of the DZFT . Since July 2018 he has been chief physician of the German Center for Fetal Surgery & Minimally Invasive Therapy at the University Hospital Mannheim (UMM) , where he works closely with the local clinic for neonatology on the postnatal care of the children he has operated on.

Main focus of work and research

Kohl is considered a pioneer of minimally invasive fetal surgery , as he introduced the new method at the University Hospital Bonn in 2002 after preliminary animal experiments . There he closed an " open back " ( spina bifida ) for the first time in an unborn child in the 25th week of pregnancy in a completely minimally invasive manner in the womb. During this operation, he also used percutaneous gas insufflation of the fruit cavity with carbon dioxide (PACI - Partial Amniotic Carbon Dioxide Insufflation) for the first time . Since then, he has continuously developed the minimally invasive procedure for treating unborn babies with spina bifida, so that from 2007 children are born who no longer need to be closed again after the birth after the operation in the womb. In 2013 he also achieved a complete skin closure of the "open back" for the first time.

In 2003, Kohl introduced the new method , which he helped develop, for the minimally invasive closure of the trachea in unborn babies (fetoscopic tracheal balloon occlusion) with life-threatening diaphragmatic hernias in Germany, in which he cooperated with the Neonatology Clinic at the University Hospital Mannheim, which specializes in newborns with this disease . Kohl first used fetoscopic tracheal balloon occlusion in 2006 to treat an unborn child with severe underdevelopment of the lungs after an early rupture of the bladder . Since 2012, he has also been using the procedure for chest filled with water on both sides ( hydrothorax ) or severe lung malformations (CPAM, CCAM ).

With the support of the DZFT, Kohl's surgical methods were introduced in São Paulo , Brazil , at Bilim University in Istanbul , Turkey , at the University of Warsaw , Poland , and at the University of Texas , USA .

In 2007 he developed the "Kohl procedure" named after him, a chronically intermittent maternal-fetal oxygen therapy for the treatment of unborn babies with too small heart and vascular structures. In 2016, a prospective controlled randomized study was published that demonstrated the effectiveness of the method using the example of unborn babies who were expected to develop coarctation of the aorta (ISTA) after their birth : Without oxygen therapy, 75 percent of the fetuses examined had to go to their ISTA after birth surgery, after prenatal oxygen therapy only 20 percent.

Memberships

Kohl is a member of the following specialist societies:

In addition, Kohl is the initiator and founding member of the Federal Association for the Accompaniment of Families with Prenatal Children (BFVEK) eV, founded in 2017. The primary goals of the non-profit association are the accompaniment and support of pregnant women with prenatal children and their families by the association members.

Awards

2015 Honorary Professorship (Prof. hc) at Bilim University, Istanbul , Turkey , for the clinical introduction of minimally invasive fetal surgery for the treatment of unborn babies with spina bifida in Turkey

2016 Honorary Professorship (Prof. hc) at the China Medical University, Shenjing, China , for international cooperation and commitment in the field of fetal surgery

Kohl is one of the first to receive the Werner Forßmann Prize from the Board of Trustees for Cardiology 2000 at the University of Bochum .

Publications

Kohl is the author and co-author of over 120 scientific articles in specialist journals and eight book chapters, and he is also a reviewer for numerous international journals, including Circulation, Fetal Diagnosis & Therapy, Lancet and Obstetrics & Gynecology.

Individual evidence

  1. Thomas Kohl: The aerobic-anaerobic threshold for spiroergometric exercise in children, adolescents and young adults with chronic kidney failure / . July 13, 2018 ( researchgate.net [accessed July 13, 2018]).
  2. DZFT - German Center for Fetal Surgery & Minimally Invasive Therapy. Retrieved on July 13, 2018 (German).
  3. UMM: Fetal Therapy: Mannheim University Hospital. Retrieved July 13, 2018 .
  4. ^ UMM: Clinic for Neonatology: University Clinic Mannheim. Retrieved July 13, 2018 .
  5. Shi Zeng, Jiawei Zhou, Qinghai Peng, Wen Deng, Ming Zhang: Sustained maternal hyperoxygenation improves aortic arch dimensions in fetuses with coarctation . In: Scientific Reports . tape 6 , no. December 1 , 2016, ISSN  2045-2322 , doi : 10.1038 / srep39304 ( nature.com [accessed July 13, 2018]).
  6. BFVEK eV | We help families with prenatal children. Retrieved on July 13, 2018 (German).
  7. Article Deutsches Ärzteblatt. Retrieved July 13, 2018 .
  8. ↑ Heart surgery in the womb. Retrieved July 13, 2018 .